Herbal medicines in children with attention deficit hyperactivity disorder (ADHD): A systematic review

Anheyer, D; Lauche, R; Schumann, D; Dobos, G; Cramer, H

Herbal medicines in children with attention deficit hyperactivity disorder (ADHD): A systematic review

Anheyer, D Lauche, R

Schumann, D Dobos, G Cramer, H

Permalink

Publication Type:: Journal Article
Citation:: Complementary Therapies in Medicine, 2017, 30 pp. 14 - 23
Issue Date:: 2017-02-01

Closed Access

	Filename	Description	Size
	Herbal medicines in children with attention deficit hyperactivity disorder (ADHD).pdf	Published Version	1.36 MB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Anheyer, D	en_US
dc.contributor.author	Lauche, R https://orcid.org/0000-0002-4171-7935	en_US
dc.contributor.author	Schumann, D	en_US
dc.contributor.author	Dobos, G	en_US
dc.contributor.author	Cramer, H	en_US
dc.date.available	2016-11-17	en_US
dc.date.issued	2017-02-01	en_US
dc.identifier.citation	Complementary Therapies in Medicine, 2017, 30 pp. 14 - 23	en_US
dc.identifier.issn	0965-2299	en_US
dc.identifier.uri	http://hdl.handle.net/10453/114711
dc.description.abstract	© 2016 Elsevier Ltd Objective The purpose of this review is to identify evidence in herbal therapy in the treatment of ADHD concerning effectiveness and drug tolerability. Method For this Medline/PubMed, Scopus and the Cochrane Central Register of Controlled Trials (Central) were searched from their inception to 15 July 2016. Only randomized controlled trails (RCT) with children (0–18 years) suffering from ADHD were included in this review. Results Nine RCTs with 464 patients comparing herbal pharmaceuticals to placebo or active control were included. Seven different herbs were tested in the treatment of ADHD symptoms. Low evidence could be found for Melissa officinalis, Valeriana officinalis and Passiflora incarnata. Limited evidence could be found for pine bark extract and Gingko biloba. The other herbal preparations showed no efficacy in the treatment of ADHD symptoms. Conclusion While there is still a lack of sufficient numbers of RCTs no concrete recommendations for use can be made so far.	en_US
dc.relation.ispartof	Complementary Therapies in Medicine	en_US
dc.relation.isbasedon	10.1016/j.ctim.2016.11.004	en_US
dc.subject.classification	Complementary & Alternative Medicine	en_US
dc.subject.mesh	Humans	en_US
dc.subject.mesh	Plants, Medicinal	en_US
dc.subject.mesh	Drugs, Chinese Herbal	en_US
dc.subject.mesh	Phytotherapy	en_US
dc.subject.mesh	Attention Deficit Disorder with Hyperactivity	en_US
dc.subject.mesh	Adolescent	en_US
dc.subject.mesh	Child	en_US
dc.subject.mesh	Child, Preschool	en_US
dc.subject.mesh	Female	en_US
dc.subject.mesh	Randomized Controlled Trials as Topic	en_US
dc.subject.mesh	Herbal Medicine	en_US
dc.title	Herbal medicines in children with attention deficit hyperactivity disorder (ADHD): A systematic review	en_US
dc.type	Journal Article
utslib.citation.volume	30	en_US
utslib.for	1104 Complementary and Alternative Medicine	en_US
utslib.for	1701 Psychology	en_US
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
pubs.organisational-group	/University of Technology Sydney/Strength - CHSP - Health Services and Practice
utslib.copyright.status	closed_access
pubs.publication-status	Published	en_US
pubs.volume	30	en_US

Abstract:

© 2016 Elsevier Ltd Objective The purpose of this review is to identify evidence in herbal therapy in the treatment of ADHD concerning effectiveness and drug tolerability. Method For this Medline/PubMed, Scopus and the Cochrane Central Register of Controlled Trials (Central) were searched from their inception to 15 July 2016. Only randomized controlled trails (RCT) with children (0–18 years) suffering from ADHD were included in this review. Results Nine RCTs with 464 patients comparing herbal pharmaceuticals to placebo or active control were included. Seven different herbs were tested in the treatment of ADHD symptoms. Low evidence could be found for Melissa officinalis, Valeriana officinalis and Passiflora incarnata. Limited evidence could be found for pine bark extract and Gingko biloba. The other herbal preparations showed no efficacy in the treatment of ADHD symptoms. Conclusion While there is still a lack of sufficient numbers of RCTs no concrete recommendations for use can be made so far.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/114711